US38246G1085 - Common Stock
GOODRX HOLDINGS INC-CLASS A
NASDAQ:GDRX (5/9/2024, 7:00:00 PM)
Premarket: 6.93 0 (0%)6.93
-0.68 (-8.94%)
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California. The company went IPO on 2020-09-23. The firm offers consumers free access for branded and generic medications, medical provider consultations via telehealth, and comprehensive healthcare research and information. The firm offers information and tools to help consumers compare prices and save on their prescription drug purchases. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing and provides access to negotiated prices through its codes across the United States (the prescription transactions offering). These services are free to consumers. The company also offers other healthcare products and services, including pharma manufacturer solutions, subscriptions and telehealth services. Its subscription offerings provide subscribers with added benefits and features, such as refill reminders, price alerts and other notifications.
GOODRX HOLDINGS INC-CLASS A
2701 Olympic Boulevard, Suite 990
Santa Monica CALIFORNIA 90404
P: 18552682822
CEO: Douglas Hirsch
Employees: 952
Website: https://investors.goodrx.com/
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX). Shareholders who purchased shares of...
GDRX earnings call for the period ending March 31, 2024.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
WHY: NEW YORK, NY - (NewMediaWire) - May 9, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022, both dates inclusive (the “Class Period”), of the important June 21, 2024 lead plaintiff deadline.
GDRX stock results show that GoodRx Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
WHY: NEW YORK, NY - (NewMediaWire) - May 08, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022, both dates inclusive (the “Class Period”), of the important June 21, 2024 lead plaintiff deadline.
Here you can normally see the latest stock twits on GDRX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: